Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you avoid adding high energy photons (with associated neutrons) for younger breast cancer patients, out of concern for secondary malignancy risk?
Answer from: Radiation Oncologist at Community Practice
We used mixed, whenever appropriate, with optimization of dose distribution using field within field technique (no wedges).
Sign in or Register to read more
9244
Related Questions
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?
How do you respond to a patient who asks "Why do I still need breast radiation after chemotherapy if chemotherapy treats the whole body?"
How would you manage a patient presenting with recurrent cT4 breast cancer?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Would you offer a patient with “good-risk” DCIS and an elevated DCISionRT score APBI or WBI?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
How would you manage new symptomatic brain metastases (10-15) in a young woman with HER2+ metastatic breast cancer?
Would you consider partial breast irradiation in patients who otherwise meet PBI guidelines who have a pathogenic variant of CHEK2 or other moderate penetrance gene?
When evaluating for PMRT in patients who did not receive neoadjuvant chemotherapy and are found to be pN0, do you utilize clinical T-staging, or pathologic T-staging?
Do you offer APBI to patients who do not have surgical clips but a visible seroma?